An eye-opening exclusive by the WSJ shows just how much time and energy is being spent by American companies and Silicon Valley venture capitalists investing in semiconductor production…in China. The U.S. needs the CHIPS Act passed this year.
A report by business intel firm Horizon Advisory shows China’s encroachment on the European steel industry. What might it mean for Section 232 tariffs against European steel?
An Indian drug market that’s been the subject of FDA warnings since 2017 is the apparent source of tainted medication sold in the U.S. and Canada. This is another example as to why we need to reshore critical supply of essential medication. Where is Congress?
The Mexican & Guatemalan governments are working against their own peoples’ interests. Rather than weakening our rules of origin, North American leaders should be united in recapturing market share lost to China.
A Deloitte survey of CFOs says that nearly half are facing serious supply chain disruptions. They all want to move away from a China-centric model. But will their new “supply chain resilience” push mean nothing for U.S. manufacturing, everything from Southeas Asia and Mexico?
The recent and ongoing National Defense Authorization Act was an emotional debate over Buy America provisions. Where do our Congressional leaders come down on this issue? Do local manufacturers have any allies in Washington?
Thanks to currencies worth peanuts, and weak environmental rules, China has turned three SE Asian nations into their solar-making vassal states. The 20% tariff against them is not enough. Here’s what Washington needs to do if it wants a domestic solar industry.